Ligand Pharmaceuticals
LGND
#4130
Rank
C$3.22 B
Marketcap
$170.88
Share price
-0.24%
Change (1 day)
69.75%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.11

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.26. In 2022 the company made an earnings per share (EPS) of -$2.85 a decrease over its 2021 EPS that were of $4.98.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-174.16%
2022-$2.85-157.23%
2021$4.98-2571.43%
2020-$0.20-100.46%
2019$44.09353.48%
2018$9.721025%
2017$0.86-700%
2016-$0.14-100.87%
2015$16.651859.32%
2014$0.855.36%
2013$0.818.0704505322479E+18%
2012$0.0000000000-100%
2011$0.71-194.23%
2010-$0.75548.38%
2009-$0.12-98.7%
2008-$8.90-136.52%
2007$24.37-787.8%
2006-$3.54-14.58%
2005-$4.15-21.31%
2004-$5.27-55.15%
2003-$11.7581.33%
2002-$6.482.74%
2001-$6.31-45.93%
2000-$11.67-14.56%
1999-$13.65-45.52%
1998-$25.06-3.97%
1997-$26.10132.31%
1996-$11.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$20.38 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.52-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.04 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.62 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.68 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.82 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.72 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.37 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.29 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA